Denali Therapeutics DNLI
NASDAQ DNLI
$20.00 -0.53 (-2.58%)
At close: Oct 2, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Return on Equity [ROE] (2018 - 2026)

Updated

Denali Therapeutics (DNLI) posted Return on Equity [ROE] of -58.07% for Q2 2026, down 13.51 percentage points from -44.56% a year earlier and down 5.70 percentage points from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025, Denali Therapeutics' Return on Equity [ROE] came in at -45.69%, down 8.29 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of -54.90 percentage points (FY2020 to FY2025).
  • In prior years, Denali Therapeutics' Return on Equity [ROE] was -37.40% in FY2024 (-23.39 pp), -14.01% in FY2023 (+18.51 pp), -32.52% in FY2022 (-5.02 pp) and -27.51% in FY2021 (-36.71 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q1 2018.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last nine quarters, with an average year-over-year change of -18.68 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2021, with a gain of 35.73 percentage points; the weakest was Q3 2022, with a drop of 38.67 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -52.37% (Q1 2026), -52.83% (Q4 2025) and -51.06% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Denali Therapeutics 3.20 Bn 3.20 Bn 3.51 Mn -58.07%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -58.07%
Mar 31, 2026 -52.37%
Dec 31, 2025 -52.83%
Sep 30, 2025 -51.06%
Jun 30, 2025 -44.56%
Mar 31, 2025 -38.59%
Dec 31, 2024 -33.18%
Sep 30, 2024 -31.60%
Jun 30, 2024 -29.53%
Mar 31, 2024 -11.04%
Dec 31, 2023 -13.51%
Sep 30, 2023 -10.80%
Jun 30, 2023 -11.92%
Mar 31, 2023 -36.89%
Dec 31, 2022 -35.31%
Sep 30, 2022 -35.84%
Jun 30, 2022 -31.64%
Mar 31, 2022 -30.53%
Dec 31, 2021 -29.43%
Sep 30, 2021 2.84%
API Access

Denali Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DNLI&period=max&api_key=YOUR_API_KEY